Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Polycystic Ovary Syndrome 11Carcinoma, Non-Small-Cell Lung 9Recurrence 7Colorectal Neoplasms 6Ovarian Neoplasms 4Neoplasm Metastasis 4Lymphoma, T-Cell, Peripheral 4Colonic Neoplasms 4Rectal Neoplasms 3Lymphoma, T-Cell 3Lung Neoplasms 3Sezary Syndrome 2Mycosis Fungoides 2Meningeal Carcinomatosis 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, B-Cell 2Lymphoma 2Infertility 2Hyperandrogenism 2Head and Neck Neoplasms 2Breast Neoplasms 2Atypical Squamous Cells of the Cervix 2Anovulation 2Adenoma 2Waldenstrom Macroglobulinemia 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Thyroid Diseases 1Thrombocytopenia 1

Interventions

Tobacco Use Cessation Devices 4Surveys and Questionnaires 4Varenicline 2Tobacco Products 2Smoking Devices 2Ethanol 2Celecoxib 2zileuton 1olaparib 1Yoga 1Vitamin B 12 1Transcranial Direct Current Stimulation 1Restraint, Physical 1Radon 1Radiotherapy 1Patient Navigation 1Nicotine Replacement Therapy 1Motivational Interviewing 1Mindfulness-Based Stress Reduction 1Mindfulness 1Interviews as Topic 1Health 1Folic Acid 1Erlotinib Hydrochloride 1Cycloserine 1Cognitive Behavioral Therapy 1Cetuximab 1Bupropion 1Budesonide 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Smoking × Folic Acid × Clear all
NCT00606502 2021-03-05

Study of Pralatrexate vs. Erlotinib for Non-Small Cell Lung Cancer After at Least 1 Prior Platinum-based Treatment

Spectrum Pharmaceuticals, Inc

Phase 2 Completed
201 enrolled 12 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Smoking

Data powered by HemOnc (CC BY 4.0) Colophon âš¡